Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3370 of 6351
-
Experimental pill aims to tame deadly inflammation in severe COVID
Disease control CompletedPrimary Objective: To evaluate the effect of SAR443122 relative to the control arm on the hyperinflammatory state as measured by C-reactive protein (CRP) levels in adult patients hospitalized with severe coronavirus disease 2019 (COVID-19) Secondary Objectives: * To evaluate t…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
DNA test could Fine-Tune blood thinners for heart patients
Knowledge-focused OngoingThe feasibility and clinical benefit of using a patient's genotype to guide antiplatelet therapy prescribing has been demonstrated. However, a more precise understanding of who to genotype, what to include on a genetic testing panel, and how to change antiplatelet therapy based o…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Radiation implants take aim at inoperable kidney cancers
Disease control Stopped earlyThis phase I/II trial investigates the side effects of interstitial brachytherapy and to see how well it works in limiting the growth of large kidney cancer masses in patients with kidney cancer that have refused or are unable to undergo surgery or ablation (unresectable/unablata…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Nasal spray test could make allergy shots smarter and cheaper
Knowledge-focused Recruiting nowThis prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone …
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Shock therapy for sex? nerve zaps may help premature ejaculation
Disease control CompletedObjective: Evaluate the effectiveness and safety of transcutaneous electrostimulation of the posterior tibial nerve alone and combined with standard pharmacological treatment, in men with primary premature ejaculation, compared to standard pharmacological treatment. Patients and…
Sponsor: Boston Medical Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Scientists investigate key immune cells in severe drug allergy
Knowledge-focused Recruiting nowDrug Hypersensitivity Syndrome or DRESS for "Drug Reaction with Eosinophilia and Systemic Symptoms" is a serious drug allergy which can be life-threatening for patients with serious organ damage. The pathophysiology of DRESS is still not fully understood. In particular, no study …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo shows promise against tough cancers
Disease control CompletedThe purpose of this study is to evaluate BMS-986315 alone and in combination with nivolumab or cetuximab in participants with advanced solid tumors.
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Spinal fluid test may forecast MS severity
Knowledge-focused Recruiting nowMultiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system, usually presenting as clinically isolated syndrome (CIS). The course of MS following first symptoms is unpredictable, as approximately 30% of patients with MS have a benign course …
Sponsor: Francis Corazza • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Win prizes, lower blood pressure: smartphone lottery boosts medication adherence
Disease control CompletedBETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recru…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New Immune-Boosting drug takes on Hard-to-Treat cancers
Disease control Recruiting nowTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy (HLA-G inhibitor) and in combination with either pembrolizumab (PD-1 inhibitor), cetuximab (EGFR inhi…
Phase 1 • Sponsor: Tizona Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New PET tracer could spot hidden heart inflammation
Diagnosis CompletedInfectious myocarditis are frequent, most of the time viral and can evolve to cardiac insufficiency. The diagnosis is difficult because they can mime an acute coronary syndrome. Approximately 10 % of patients with acute infarction suspected, have a normal angiography, and half of…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Pandemic's hidden toll: young cancer survivors under stress
Knowledge-focused Recruiting nowThe study investigates how the COVID-19 pandemic has impacted the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. AYA cancer survivors have inferior long-term survival compared to the general population,…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can an online happiness course ease the burden of Alzheimer's caregiving?
Symptom relief CompletedThe goal of the proposed intervention, called LEAF (Life Enhancing Activities for Family Caregivers) is to reduce burden and increase well-being in Alzheimer's Disease caregivers through the practice of positive emotion skills. We will employ two methods of online delivery of LEA…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Scientists uncover clues to how MS drug calms the immune system
Knowledge-focused CompletedThe main objective of the project is therefore to study and thus better understand the immunomodulatory / anti-inflammatory effects of cladribine during multiple sclerosis. Most current and developing therapies targeting the immune system have no effect on the progressive phase …
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New immunotherapy combo tackles Hard-to-Treat cancers
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, drug-levels, drug-effects and preliminary anti-tumor activity of DF6002 alone and in combination with Nivolumab in participants with advanced solid tumors.
Phase 1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Electric pulses and chemo aim to stop pancreatic cancer return
Disease control OngoingThe aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy (ECT) with bleomycin in pancreatic cancer in clinical study phase I and II. After surgical resection of pancreatic cancer, the posterior resection surface will be treated with ECT with the inten…
Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Rare brain tumor registry launches to unlock secrets of ETMR
Knowledge-focused Recruiting nowThis research is being done to find out more information about a brain tumor called Embryonal Tumor with Multilayer Rosettes (ETMR) by collecting medical information from children who have this disease. The purpose of this research study is to create and maintain a research data…
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Experimental cancer drug JNJ-70218902 tested in 82 patients
Disease control CompletedThe purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) and maximum tolerated dose (MTD) of JNJ-70218902 in Part 1, and to determine the safety of JNJ-70218902 RP2D(s) in Part 2.
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a Child's cancer be inherited? new study digs into family DNA
Knowledge-focused CompletedBackground. Cancer is the leading cause of death by disease in children. Most pediatric tumors differ from adult tumors in terms of biological and clinical characteristics. In children, the part of genetic determinism could be higher since the role of environmental factors may be…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug cocktail aims to prime immune system against aggressive breast cancer before surgery
Disease control OngoingThis is single arm study of a window of opportunity in which participants with previously untreated triple negative breast cancers (TNBC) who are candidates for potentially curative surgery will receive lenvatinib 12 mg daily for 7 and pembrolizumab 200 mg IV on day 1 prior to su…
Phase 1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC